THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
178,040,270
Share change
+20,854,102
Total reported value
$1,167,923,446
Put/Call ratio
82%
Price per share
$6.56
Number of holders
151
Value change
+$136,966,572
Number of buys
81
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2018

As of 30 Sep 2018, THERAPEUTICSMD INC - COM (TXMD) was held by 151 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 178,040,270 shares. The largest 10 holders included Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, BlackRock Inc., Vanguard Group Inc, FMR LLC, FRANKLIN RESOURCES INC, DARUMA CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Voya Investment Management LLC. This page lists 151 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.